Humans

Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation.

Ikegame K, Kato R, Fujioka T, Okada M, Kaida K, Ishii S, et al. Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation. International journal of hematology//Int J Hematol. 2013;97(2):287-90.

Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis.

Tolpin MD, Stewart JA, Warren D, Mojica BA, Collins MA, Doveikis SA, et al. Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. The Journal of pediatrics//J Pediatr. 1985;107(6):953-6.

Donor origin of BKV replication after kidney transplantation.

Schmitt C, Raggub L, Linnenweber-Held S, Adams O, Schwarz A, Heim A. Donor origin of BKV replication after kidney transplantation. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology//J Clin Virol. 2014;59(2):120-5.

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.

Hewitt PE, Llewelyn CA, Mackenzie J, Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox sanguinis//Vox Sang. 2006;91(3):221-30.

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet//Lancet. 2004;364(9433):527-9.

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet//Lancet. 2004;363(9407):417-21.

Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries.

Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion//Transfusion. 1991;31(6):547-57.

Is it safe to use a liver graft from a Chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation.

Goldaracena N, Wolf MM, Quinonez E, Anders M, Mastai R, McCormack L. Is it safe to use a liver graft from a Chagas disease-seropositive donor in a human immunodeficiency virus-positive recipient? A case report addressing a novel challenge in liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society//Liver Transpl. 2012;18(8):979-83.

Chagas' disease and kidney donation.

Marquez E, Crespo M, Mir M, Perez-Saez MJ, Quintana S, Barbosa F, et al. Chagas' disease and kidney donation. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia//Nefrologia. 2013;33(1):128-33.

Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors.

Cura CI, Lattes R, Nagel C, Gimenez MJ, Blanes M, Calabuig E, et al. Early molecular diagnosis of acute Chagas disease after transplantation with organs from Trypanosoma cruzi-infected donors. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons//Am J Transplant. 2013;13(12):3253-61.

Pages